Form 4: Alx Oncology Holdings CEO Sells Shares
Insider Transaction (Form 4)
Jason Lettmann, CHIEF EXECUTIVE OFFICER and a Director of Alx Oncology Holdings Inc, sold 2,230 shares of common stock on August 17, 2026 for $1.93 per share.
Summary
- Open-market sale: disposed of 2,230 Common Stock at $1.93 ($4,304) on August 17, 2026; holds 294,379 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative signal: an insider sold $4,304 of stock on the open market.
Insider Transactions
Jason Lettmann — Director, Officer (CHIEF EXECUTIVE OFFICER)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-17 | Open-market sale | Common Stock | 2,230 | $2 | $4.3K | 294,379 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-17 | Open-market sale (2,230 shares) |
Keywords
insider transaction, Form 4, ALXO, ALX ONCOLOGY HOLDINGS INC, bearish, Jason Lettmann
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.